Standard BioTools
LAB
LAB
109 hedge funds and large institutions have $179M invested in Standard BioTools in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 43 reducing their positions, and 24 closing their positions.
Holders
109
Holders Change
-12
Holders Change %
-9.92%
% of All Funds
1.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
26
Reduced
43
Closed
24
Calls
$214K
Puts
$877K
Net Calls
-$663K
Net Calls Change
-$1.6M
Top Buyers
1 |
1
Morgan Stanley
New York
|
$10.6M |
2 |
PVI
2
Pura Vida Investments
New York
|
$3.05M |
3 |
FAM
3
Fred Alger Management
New York
|
$1.44M |
4 |
NIM
4
Needham Investment Management
New York
|
$13.6M |
5 |
5
Rockefeller Capital Management
New York
|
$405K |